A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma.
Janice M. Mehnert
Research Funding - Bayer/Onyx
Neha Semlani
No relevant relationships to disclose
Yvonne Wen
No relevant relationships to disclose
Antoinette R. Tan
Research Funding - Bayer/Onyx
Rebecca Anne Moss
No relevant relationships to disclose
Shari Adams
No relevant relationships to disclose
Mark N. Stein
No relevant relationships to disclose
Mikel Ross
No relevant relationships to disclose
Michael P. Kane
No relevant relationships to disclose
Darlene Gibbon
No relevant relationships to disclose
John Joseph Wright
No relevant relationships to disclose
Joseph Aisner
No relevant relationships to disclose
Suzie Chen
No relevant relationships to disclose
James S Goydos
No relevant relationships to disclose